13058_2018_971_MOESM9_ESM.pptx (70.52 kB)

Additional file 9: of OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung

Download (70.52 kB)
posted on 2018-06-14, 05:00 authored by Ken Tawara, Celeste Bolin, Jordan Koncinsky, Sujatha Kadaba, Hunter Covert, Caleb Sutherland, Laura Bond, Joseph Kronz, Joel Garbow, Cheryl Jorcyk
Figure S8. OSM inhibits proliferation of 4T1.2 cells. One hundred 4T1.2 cells were plated at day 0 and treated with 25 ng/ml of OSM. By day 7, there was a 20% reduction in total cell numbers in the OSM-treated group versus the non-OSM-treated group. Data are expressed as mean ± SEM. *p < 0.05, **p < 0.01; statistical analysis was performed for each day using a two-tailed Student’s t test. (PPTX 21 kb)


National Cancer Institute